Wella Co S-1/Aamended IPO prospectus

Executive Summary

Wella sells hair color, care products, styling tools and nail products to salons, distributors, retailers and consumers. Its “Pro + Consumer” strategy extends salon brands into retail and e-commerce while using professional color relationships to sell more care products. Revenue growth slowed from 9.2% in FY2026 to 4.1% in Q1 FY2027; FY2026 net income attributable to Rainbow Capital Group was just $2.7M, reflecting preferred interests’ claims on earnings. The IPO remains unpriced, preventing valuation or buyer-stake calculations; investors are considering a controlled company whose case rests on brand-led growth, stronger cash conversion and refinancing that reduces financing costs.

Business Model and Growth Drivers

Professional Hair is the core engine: FY2026 revenue reached $1.64B, up 9.0%, contributing more than half of consolidated revenue growth. Wella Professionals sells salon color and care; Clairol and Wella/Koleston address retail color; Sebastian Professional and Nioxin extend styling and care; OPI supplies nail products; and ghd sells premium electrical styling tools. Wella Professionals ranks first globally in salon hair color, supporting repeat purchases and cross-selling. Styling Tools revenue grew 14% to $478M, making ghd another meaningful growth contributor.

“Gain with Color, Grow with Care” uses a direct sales organization serving over 65,000 salons within a broader network exceeding 250,000. FY2026 salon revenue retention was 97%, measuring retained prior-year sales from directly serviced accounts and excluding new salons. Wella added ≈4,700 priority salon locations. Wella Professionals care revenue grew at ≈22% annually in constant currency from FY2024–FY2026.

Consumer channels reached ≈52% of FY2026 net invoiced sales, vs ≈45% in FY2023; this measure precedes discounts and rebates. E-commerce and marketplaces represented ≈23%. Expansion increases reach but risks weakening professional exclusivity.

Innovation supplied ≈7% of FY2026 revenue, vs 5% in FY2024, counting genuinely new products during their first year. Hair & Nail launch times fell from ≈19 to 13 months. Three owned factories supply ≈60% of Hair & Nail products; ghd manufacturing is outsourced. Three customers generated 19% of revenue, increasing buyers’ negotiating leverage.

The Offering

• The offering is unpriced: price, share count, primary/secondary split and proceeds remain blank. Outstanding and fully diluted market capitalization, buyer ownership and valuation multiples therefore cannot be calculated; employee-award and WOW issuance share counts also remain unresolved.
• Wella applied for NYSE listing as WELA. Goldman Sachs and BofA Securities lead the underwriting; underwriters have a 30-day additional-share option.
• Company proceeds and new borrowings will repay Facility B and fund taxes associated with employee equity transactions—not solely business investment. A KKR-affiliated lender will receive repayment, interest and fees, while KKR Capital Markets underwrites the deal. Goldman Sachs serves as qualified independent underwriter for this conflict.
• New commitments comprise €850M, $500M and £100M term facilities plus a $500M revolver, initially priced at benchmark rates plus 2.25%. These are commitments, not post-IPO debt balances. Final capitalization and per-share tangible-asset backing cannot yet be quantified.
• Directors, executives and substantially all existing holders face 180-day lock-ups covering exchange and WOW shares. Wella has no current dividend plans, making returns dependent on business value and eventual share-price appreciation.

Key Financial Highlights

Historical operating-group figures; fiscal years end 6/30. Quarterly periods end 9/30. Dollar amounts in $M.

• Growth quality: FY2026 constant-currency growth was 5.1%; favorable exchange rates added $108M. Q1 FY2027 constant-currency growth slowed to 4.3%, with pricing supplying about two-thirds.
• Profit quality: FY2026 trademark impairments were $84.2M, including $68.7M for Briogeo and $15.5M for OPI. Digital-content claims generated a $40M accrual offset by $28M of probable insurance recovery.
• Cash conversion: quarterly working-capital movements consumed $195M, including $101M in receivables and $32.8M in inventory; seasonal stocking and collection timing explain the divergence from profit.
• Equity deficit: $2.40B of redeemable preferred stock and $823M of redeemable noncontrolling interests sit outside equity; compounded preferred claims and historical losses help explain the deficit, which is not simply borrowing. Preferred contractual allocations also divert earnings from RCGL. Post-IPO balances remain unquantified.

Governance and Control

• Common shares carry one vote, but KKR expects majority voting control. Wella intends to use controlled-company exemptions, reducing independent-governance protections.
• KKR can nominate a board majority while owning at least 50%, retains nomination rights down to 5%, and has major-transaction approval rights at 25%. A staggered board further limits outside influence.
• Calvin McDonald became CEO in 4/2026. The IPO is expected to trigger $39.3M of restricted-stock-unit compensation expense; additional awards may create further expense and dilution. The employee WOW pool starts at ≈4% of equity-value appreciation since KKR’s acquisition.
• KKR’s monitoring agreement ends at the IPO, potentially triggering a termination payment from company cash.

Risk Assessment

• Controls: FY2024 tax-accounting and currency-translation weaknesses were reported remediated in FY2025, but recurrence could undermine reporting reliability.
• Debt: variable-rate borrowing, expired interest-rate hedges and seasonal cash demands leave refinancing and cash conversion critical.
• Channel conflict: broader consumer distribution could alienate salons while concentrated retail customers demand better terms.
• Product litigation: hair-dye and predecessor hair-relaxer cancer claims carry no current mass-tort reserves and potentially substantial uninsured exposure.
• Reformulation: resorcinol appears in most oxidative color products; replacements may compromise performance or customer acceptance.
• Supply concentration: three owned plants and one North American delivery provider create disruption exposure.

What to Watch

• Salon-led expansion: retention is strong and care is growing rapidly; later filings should show consumer expansion reinforcing professional sales, rather than weakening salon relationships.
• Reformulation: ≈half the resorcinol portfolio has transitioned; management targets completion by FY2030. Watch for successful replacements versus quality problems or lost sales.
• Cash conversion: annual FCF improved, but Q1 consumed cash. Subsequent collections and inventory normalization would support the recovery; persistent outflows would weaken it.
• Final deal economics: pricing must establish valuation, fully diluted ownership, employee dilution and actual post-refinancing debt before the investment case can be judged.